Sort
78,016 grants matching “breast cancer”
South Carolina Cancer Disparities Research Center (SC CaDRe)
$1,261,263Judith Salley · South Carolina State University · U54 · FY2018 · CA
PROSPR Statistical Coordinating Center (PSCC)
$1,261,143William E Barlow · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA
THERAPEUTIC REACTIVATION OF THE PP2A TUMOR SUPPRESSOR FOR BREAST CANCER TREATMENT
$1,261,131Regents Of The University Of Michigan · · FY2020 · Defense Health Agency
MRI: Acquisition of a Multipole Wiggler for the LSU Synchrotron for Protein Crystallography, Tomography, X-ray Absorption, Radiology, and Microfabrication
$1,261,000Marcia Newcomer · Louisiana State University · · FY2009 · MPS
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
$1,259,994David Salomon · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
University of Texas PDX Development and Trial Center
$1,259,703Jack Roth · University Of Tx Md Anderson Can Ctr · U54 · FY2021 · CA
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
$1,259,246Nathan J McDannold · Brigham And Women'S Hospital · P01 · FY2015 · CA
WFUSM Macaca fascicularis SPF Breeding Colony
$1,259,218Janice D. Wagner · Wake Forest University Health Sciences · P40 · FY2011 · RR
TARGETING CDK4/6 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASIS
$1,259,101Dana-Farber Cancer Institute, Inc. · · FY2018 · Department of the Army
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
$1,259,003Duane T. Smoot · Howard University · U54 · FY2009 · CA
EXPLORING ANTITUMOR IMMUNE RESPONSE IN A NOVEL MLL3-MUTANT BREAST CANCER MODEL
$1,258,772Albert Einstein College Of Medicine · · FY2021 · Defense Health Agency
Comparative Modeling: Informing Breast Cancer Control Practice & Policy
$1,257,743Jeanne Mandelblatt · Georgetown University · U01 · FY2010 · CA
Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers
$1,257,340Laura J Esserman · University Of California, San Francisco · U01 · FY2018 · CA
Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center
$1,256,574John J Heine · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2024 · CA
SMALL MOLECULE INHIBITION OF THE OLIGOSACCHARYLTRANSFERASE FOR THE TREATMENT OF BREAST CANCER
$1,256,250Yale Univ · · FY2017 · Department of the Army
Early Life Exposures and Subsequent Cancer Risk
$1,256,072Montserrat Garcia-Closas · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
$1,255,813David Salomon · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
The Funding Mechanism of the Pilot Trial
$1,255,179Olufunmilayo I Olopade · University Of Chicago · R01 · FY2025 · CA
Multi Source E-Beam kV X-Ray Tube for Image-Guided Radiotheraphy
$1,254,926Douglas P Boyd · Telesecurity Sciences, Inc. · R44 · FY2016 · CA
An Open-Labeled, Single Arm Phase 2 Efficacy and Safety Study of REM-001 Photodynamic Therapy (PDT) for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)
$1,254,180Dennis Brown · Kintara Therapeutics, Inc. · R44 · FY2023 · CA
FFNP-PET as a predictive biomarker of response to endocrine therapy approaches in advanced breast cancer
$1,254,028Kooresh Isaac Shoghi · Washington University · R01 · FY2025 · CA
Impact of Stretching on Tumor growth and Metastasis
$1,254,000Helene Langevin · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE
Loma Linda University Center for Health Disparities Research
$1,253,971Marino De Leon · Loma Linda University · P20 · FY2014 · MD
Center of Excellence for Health Disparties in the Nation's Capital
$1,253,969Lucile L Adams-Campbell · Georgetown University · P60 · FY2015 · MD
Breast Cancer Family Registry
$1,253,227Mary Beth Terry · Columbia University Health Sciences · U01 · FY2024 · CA